Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment outcomes in NTM-PD in a high TB burden context.
Kang S, Schmidt JE, Chen I, Tiberi S. Kang S, et al. Among authors: tiberi s. IJTLD Open. 2024 Dec 1;1(12):547-555. doi: 10.5588/ijtldopen.24.0413. eCollection 2024 Dec. IJTLD Open. 2024. PMID: 39679205 Free PMC article.
Tuberculosis in adult migrants in Europe: a TBnet consensus statement.
Kunst H, Lange B, Hovardovska O, Bockey A, Zenner D, Andersen AB, Hargreaves S, Pareek M, Friedland JS, Wejse C, Bothamley G, Guglielmetti L, Chesov D, Tiberi S, Matteelli A, Mandalakas AM, Heyckendorf J, Eimer J, Malhotra A, Zamora J, Vasiliu A, Lange C; TBnet. Kunst H, et al. Among authors: tiberi s. Eur Respir J. 2024 Dec 13:2401612. doi: 10.1183/13993003.01612-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39672603 Review.
Expert views on screening for tuberculosis infection in patients commencing treatment with a biologic agent.
Sultana A, Migliori GB, D'Ambrosio L, García-García JM, Silva DR, Rendon LA, Codecasa LR, Blanc FX, Tiberi S, Ong CWM, Heffernan C, Sotgiu G, Centis R, Dobler CC; Global Tuberculosis Network. Sultana A, et al. Among authors: tiberi s. J Bras Pneumol. 2024 Sep 27;50(4):e20240082. doi: 10.36416/1806-3756/e20240082. eCollection 2024. J Bras Pneumol. 2024. PMID: 39356910 Free PMC article.
IsoBayes: a Bayesian approach for single-isoform proteomics inference.
Bollon J, Shortreed MR, Jordan BT, Miller R, Jeffery E, Cavalli A, Smith LM, Dewey C, Sheynkman GM, Tiberi S. Bollon J, et al. Among authors: tiberi s. bioRxiv [Preprint]. 2024 Jun 11:2024.06.10.598223. doi: 10.1101/2024.06.10.598223. bioRxiv. 2024. PMID: 38915658 Free PMC article. Preprint.
Candidate anti-tuberculosis medicines and regimens under clinical evaluation.
Hoelscher M, Barros-Aguirre D, Dara M, Heinrich N, Sun E, Lange C, Tiberi S, Wells C. Hoelscher M, et al. Among authors: tiberi s. Clin Microbiol Infect. 2024 Sep;30(9):1131-1138. doi: 10.1016/j.cmi.2024.06.016. Epub 2024 Jun 22. Clin Microbiol Infect. 2024. PMID: 38909687 Free article. Review.
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
Diacon AH, Barry CE 3rd, Carlton A, Chen RY, Davies M, de Jager V, Fletcher K, Koh GCKW, Kontsevaya I, Heyckendorf J, Lange C, Reimann M, Penman SL, Scott R, Maher-Edwards G, Tiberi S, Vlasakakis G, Upton CM, Aguirre DB. Diacon AH, et al. Among authors: tiberi s. Nat Med. 2024 Mar;30(3):896-904. doi: 10.1038/s41591-024-02829-7. Epub 2024 Feb 16. Nat Med. 2024. PMID: 38365949 Free PMC article. Clinical Trial.
221 results